CIC
SAGE

Cornercap Investment Counsel’s Sage Therapeutics SAGE Stock Holding History

Cornercap Investment Counsel’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,935
Closed -$119K – 628
2024
Q2 		$119K Sell
10,935
-113
-1% -$1.45K 0.02% 568
2024
Q1 		$207K Hold
11,048
– – 0.03% 560
2023
Q4 		$239K Sell
11,048
-18
-0.2% -$357 0.04% 511
2023
Q3 		$228K Buy
+11,066
New +$320K 0.04% 481
2023
Q2 		– Sell
-4,984
Closed -$209K – 651
2023
Q1 		$209K Buy
+4,984
New +$214K 0.04% 499

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return